UnitedHealth Group Incorporated $UNH Shares Sold by Laraway Financial Advisors Inc

Laraway Financial Advisors Inc reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 6.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,933 shares of the healthcare conglomerate’s stock after selling 218 shares during the quarter. Laraway Financial Advisors Inc’s holdings in UnitedHealth Group were worth $915,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of UNH. Tyche Wealth Partners LLC lifted its stake in shares of UnitedHealth Group by 8.3% in the 2nd quarter. Tyche Wealth Partners LLC now owns 5,127 shares of the healthcare conglomerate’s stock valued at $1,599,000 after purchasing an additional 394 shares in the last quarter. KLP Kapitalforvaltning AS grew its stake in UnitedHealth Group by 3.2% during the second quarter. KLP Kapitalforvaltning AS now owns 326,335 shares of the healthcare conglomerate’s stock worth $101,807,000 after buying an additional 10,100 shares during the period. Hardy Reed LLC raised its stake in shares of UnitedHealth Group by 41.7% in the 2nd quarter. Hardy Reed LLC now owns 5,933 shares of the healthcare conglomerate’s stock valued at $1,851,000 after acquiring an additional 1,745 shares during the period. Spear Holdings RSC Ltd purchased a new stake in UnitedHealth Group during the 2nd quarter worth $62,688,000. Finally, Country Club Bank lifted its stake in shares of UnitedHealth Group by 120.6% during the second quarter. Country Club Bank now owns 18,567 shares of the healthcare conglomerate’s stock worth $5,739,000 after purchasing an additional 10,151 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. Truist Financial raised their target price on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a report on Tuesday, September 9th. UBS Group reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Oppenheimer lowered their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. KeyCorp decreased their price objective on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Finally, Barclays lifted their target price on UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a research report on Thursday, September 4th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $358.95.

UnitedHealth Group Stock Down 0.3%

NYSE:UNH opened at $358.95 on Tuesday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a 50-day simple moving average of $309.38 and a 200 day simple moving average of $352.34. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The company has a market capitalization of $325.09 billion, a price-to-earnings ratio of 15.55, a price-to-earnings-growth ratio of 2.34 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the business posted $6.80 EPS. UnitedHealth Group’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.